Sandra Sánchez y Oldenhage
Independent Director
- 35+ years of experience in steering mature, start-up, and turn-around/restructuring enterprises toward tangible, sustainable growth within diverse international markets
- President and CEO of PharmAdvice, a consulting firm offering pharmaceutical, medical device and biotech guidance to healthcare companies entering or operating in Mexico
- Director on the board of directors of Fenix Holding and Farmapiel, specifically holding the title of chair of the nominations, compensation, and governance committee at Fenix Holding, in addition to serving as a regional board member of Grupo Financiero Banorte
- Previously, she oversaw oncology operations for the North LatAm region at Novartis
- Former chair of the Pharma Industry Trade Association (AMIIF) in Mexico
- Worked at several of the world’s leading pharmaceutical companies, including as president of Biogen’s Mexico affiliate, general manager, and country president for Amgen Inc., and as CEO of Probiomed
- B.S. in business administration at Universidad Intercontinental in Mexico City, Mexico
Independent Director